Last update:
HIV & AIDS news
How HIV hijacks a cellular 'gateway' to infect resting immune cells
Researchers from Queen Mary University of London have uncovered a previously unknown mechanism by which HIV-1 can infect resting immune cells. The discovery challenges a decades-old assumption in HIV biology, and opens new ...
May 6, 2026
0
5
Marker of biological aging linked to cognitive symptoms of depression
Blood tests measuring the aging of certain white blood cells can predict cognitive and mood-related symptoms of depression, rather than physical symptoms. These findings, published in The Journals of Gerontology, Series A: ...
May 4, 2026
0
5
FDA approves once-daily Idvynso tablet for treating HIV
The U.S. Food and Drug Administration has approved Merck's Idvynso (doravirine/islatravir), a new, once-daily, two-drug single tablet for the treatment of HIV-1 infection in adults to replace the current antiretroviral regimen ...
May 1, 2026
0
21
The Bangui operation: A story of blood, science and biomedical exploitation
In the early 1990s, a secret HIV vaccine research project was carried out in the Central African Republic. The project didn't yield results and was hidden for many years. Today it sheds light on debates over clinical trials, ...
May 1, 2026
0
4
New HIV vaccine design trains immune system to hit shared viral target across variants
Researchers at Karolinska Institutet, in collaboration with colleagues at The Scripps Research Institute and Emory University, have developed a new vaccine strategy that has generated antibodies capable of neutralizing highly ...
Apr 29, 2026
0
15
HIV disrupts lung 'clock,' raising COPD and emphysema risk
People living with HIV face a greater risk of developing lung diseases at a much younger age, even if they have never smoked. FIU researchers have now uncovered a previously unknown mechanism that helps explain how HIV causes ...
Apr 25, 2026
0
7
Long-acting HIV shots appeal to many but uptake remains low
When it comes to HIV medication, many patients think they'd prefer an occasional injection over a daily pill, but uptake remains an issue, according to a Rutgers Health-led survey. When researchers surveyed 801 people living ...
Apr 23, 2026
0
5
How life-saving HIV therapy has contributed to increased rates of a sexually transmitted disease
A study in Health Economics uncovered an unintended consequence of a major medical breakthrough: while the availability of HIV treatments in the late 1990s dramatically improved survival, they also contributed to a resurgence ...
Apr 22, 2026
0
4
HIV's earliest immune battle leaves blood traces that forecast powerful antibodies years later
Some people living with HIV develop antibodies capable of neutralizing many different strains of the virus. New research links this to immune responses that occur early in infection. The findings, published in PLOS Pathogens, ...
Apr 21, 2026
0
11
Scientists map how HIV hijacks human cells—and how cells can fight back
The human immunodeficiency virus (HIV), which is the cause of AIDS, is a master of deception, using just nine genes to hijack the complex cellular machinery of the human body. Yet, even after decades of research on how the ...
Apr 20, 2026
0
49
AIDS relief program sees drops in testing and diagnoses after disruptions
New data released Friday show that the President's Emergency Plan for AIDS Relief (PEPFAR) treated about the same number of people in the last quarter of 2025 as it did a year earlier in 2024.
Apr 20, 2026
0
2
HIV treatment reduces accelerated biological aging by nearly four years, landmark study shows
A major study presented at ESCMID Global 2026 has found that antiretroviral therapy (ART) reduces accelerated biological aging in people with HIV (PWH) by nearly four years, a finding that could transform how clinicians monitor ...
Apr 19, 2026
0
10
Norway's 'Oslo patient' reaches HIV remission after rare stem cell transplant donated by brother
A Norwegian man has been effectively cured of HIV after receiving a stem cell transplant from his brother, doctors announced on Monday.
Apr 13, 2026
0
23
Researchers demonstrate drug's effectiveness in drawing out dormant HIV from immune cells
Human immunodeficiency virus-1 (HIV) is one of the most challenging viruses for doctors to treat. Even with effective antiretroviral therapy, immune cells infected with HIV can hide and lie inactive in certain areas of the ...
Apr 13, 2026
0
13
Doctors can refuse to treat LGBTQ+ patients in several states—religious exemption laws decrease HIV testing
An increasing number of U.S. states have passed laws that allow health care providers—including doctors, nurses, and pharmacists—to refuse to treat patients based on their personal or religious beliefs. While these conscientious ...
Apr 13, 2026
0
2
Gut bacteria linked to levels of latent HIV
The composition of gut bacteria appears to be associated with how much latent HIV remains in the blood of people receiving antiretroviral therapy. This is shown in a new study from Karolinska Institutet, published in Gut ...
Apr 9, 2026
0
8
Study predicts HIV infections could rise 10% if CDC testing funds end
Timely HIV diagnosis and treatment are critical to preventing transmission. To help make this happen, the U.S. Centers for Disease Control and Prevention (CDC) provides funding for HIV testing to local health departments ...
Apr 7, 2026
0
8
US sexual health report card: High pleasure, low testing, stark gender disparities
A new sexual health survey reveals a mix of progress and persistent gaps. Overall, many Americans report positive experiences—interest in having sex, sexual pleasure, and good communication with partners—yet women and gender-diverse ...
Apr 6, 2026
0
6
Switching to integrase inhibitors from protease inhibitors is associated with new diabetes risk in people with HIV
Diabetes mellitus affects more than 10% of people with HIV, and its incidence is rising as the population ages, according to the National Institutes of Health. Antiretroviral therapies that treat HIV by blocking specific ...
Mar 30, 2026
0
5
Q&A: How studying two different viruses can lead to new strategies for more potent antiviral treatments
Beyond both being viruses, HIV-1 and SARS-CoV-2 don't seem to have a lot in common. HIV-1 is a retrovirus that integrates with its host's DNA for life and can be passed down from mother to child, while SARS-CoV-2 is contagious ...
Mar 30, 2026
0
4
The US is driving a public health emergency of international concern, say researchers
The Trump administration's decision to halt most US foreign aid and development work constitutes a public health emergency of international concern (PHEIC) under international law, argue experts in The BMJ.
Mar 25, 2026
0
9
Existing medication can restore HIV-affected immune cells
HIV exhausts the body's immune system by overactivating it, despite effective antiviral treatment. Researchers from Linköping University in Sweden have conducted cell studies showing that an existing medication restores immune ...
Mar 23, 2026
0
27
Dual immune response may keep HIV in check without medication
Imagine a game of chess where your opponent's king is in check. It cannot move, but the game is not over—the piece remains on the board. This is how the body might control HIV on its own: The virus would be contained and ...
Mar 23, 2026
0
17
Why some people naturally control HIV even after stopping therapy—and how we can leverage that to treat others
For millions of people living with HIV, a daily regimen of medications is a lifelong necessity. If they stop taking the drugs—commonly referred to as antiretroviral therapy—the virus usually rushes back within weeks. But ...
Mar 20, 2026
0
81
Multi-strain probiotic therapy shows promise in preventing bacterial vaginosis recurrence
A global team of experts has identified a promising new approach to prevent recurrence of bacterial vaginosis (BV), a condition that affects millions of women worldwide. In a Phase I randomized clinical trial of women in ...
Mar 18, 2026
0
7
